Exact Mass: 311.1216
Exact Mass Matches: 311.1216
Found 259 metabolites which its exact mass value is equals to given mass value 311.1216,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
IMAZAQUIN
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7950; ORIGINAL_PRECURSOR_SCAN_NO 7948 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7948; ORIGINAL_PRECURSOR_SCAN_NO 7947 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3770; ORIGINAL_PRECURSOR_SCAN_NO 3769 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3779; ORIGINAL_PRECURSOR_SCAN_NO 3778 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3762; ORIGINAL_PRECURSOR_SCAN_NO 3761 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7947; ORIGINAL_PRECURSOR_SCAN_NO 7945 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3761; ORIGINAL_PRECURSOR_SCAN_NO 3760 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7928; ORIGINAL_PRECURSOR_SCAN_NO 7927 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7919; ORIGINAL_PRECURSOR_SCAN_NO 7918 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7962; ORIGINAL_PRECURSOR_SCAN_NO 7957 CONFIDENCE standard compound; INTERNAL_ID 1252; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3745; ORIGINAL_PRECURSOR_SCAN_NO 3744 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3711
Acronydine
An organic heterotetracyclic compound that is 3H-furo[2,3-b]pyrano[3,2-f]quinoline carrying a gem-dimethyl group at position 3 as well as two methoxy substituents at positions 5 and 11.
Tolazamide
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4274; ORIGINAL_PRECURSOR_SCAN_NO 4272 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4225; ORIGINAL_PRECURSOR_SCAN_NO 4223 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4245; ORIGINAL_PRECURSOR_SCAN_NO 4243 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4316; ORIGINAL_PRECURSOR_SCAN_NO 4314 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4224; ORIGINAL_PRECURSOR_SCAN_NO 4220 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8447; ORIGINAL_PRECURSOR_SCAN_NO 8445 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8470; ORIGINAL_PRECURSOR_SCAN_NO 8469 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8494; ORIGINAL_PRECURSOR_SCAN_NO 8491 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8497; ORIGINAL_PRECURSOR_SCAN_NO 8496 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8468; ORIGINAL_PRECURSOR_SCAN_NO 8463 CONFIDENCE standard compound; INTERNAL_ID 272; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8506; ORIGINAL_PRECURSOR_SCAN_NO 8504
N2N2-Dimethylguanosine
CONFIDENCE standard compound; INTERNAL_ID 311 N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA.
N2,N2-Dimethylguanosine
N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. The mean levels of urinary N2,N2-Dimethylguanosine in the patients with colorectal cancer are significantly higher than those in patients with intestinal villous adenoma or the healthy adults (PMID 15991285). N2,N2-Dimethylguanosine has been identified in the human placenta (PMID: 32033212). N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA. N2,N2-Dimethylguanosine is an urinary nucleoside, a primary degradation product of tRNA.
Norisodomesticine
Norisodomesticine is found in herbs and spices. Norisodomesticine is an alkaloid from the leaves Laurus nobilis (bay laurel). Alkaloid from the leaves Laurus nobilis (bay laurel). Norisodomesticine is found in tea, sweet bay, and herbs and spices.
Annocherine B
Annocherine B is found in fruits. Annocherine B is an alkaloid from Annona cherimola (cherimoya Alkaloid from Annona cherimola (cherimoya). Annocherine B is found in fruits.
(S)-Nandigerine
(S)-Nandigerine is found in herbs and spices. (S)-Nandigerine is an alkaloid from Laurus nobilis (bay laurel). Alkaloid from Laurus nobilis (bay laurel). (S)-Nandigerine is found in tea, sweet bay, and herbs and spices.
(+)-Norushinsunine N-oxide
(+)-Norushinsunine N-oxide is an alkaloid from Cananga odorata (ylang ylang
1,7-Dimethylguanosine
1,7-dimethylguanosine is a modified ribonucleoside. 1,7-dimethylguanosine is formed in tRNA enzymatic methylation. 1,7-Dimethylguanosine was found to be formed in high amounts in the tRNA methylation reaction at high concentrations of methylating agents.1,7-dimethylguanosine has a possible connection to chemical cancerogenesis and to the aberrant increase of tRNA methylases activity in tumor tissues. The amount of 1,7-dimethylguanosine produced by the kidney is higher than that produced by the liver. The immediate precursor in the formation of 1,7-dimethylguanosine in tRNA appears to be 1-methylguanosine. An accumulation of modified ribonucleosides appears in the serum of uremic patients. (PMID: 7046770, 6164398, 7259877, 7159514, 9607216) [HMDB] 1,7-dimethylguanosine is a modified ribonucleoside. 1,7-dimethylguanosine is formed in tRNA enzymatic methylation. 1,7-Dimethylguanosine was found to be formed in high amounts in the tRNA methylation reaction at high concentrations of methylating agents.1,7-dimethylguanosine has a possible connection to chemical cancerogenesis and to the aberrant increase of tRNA methylases activity in tumor tissues. The amount of 1,7-dimethylguanosine produced by the kidney is higher than that produced by the liver. The immediate precursor in the formation of 1,7-dimethylguanosine in tRNA appears to be 1-methylguanosine. An accumulation of modified ribonucleosides appears in the serum of uremic patients. (PMID: 7046770, 6164398, 7259877, 7159514, 9607216).
Tolazamide
Tolazamide is only found in individuals that have used or taken this drug. It is a sulphonylurea hypoglycemic agent with actions and uses similar to those of chlorpropamide. [PubChem]Sulfonylureas likely bind to ATP-sensitive potassium-channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Depolarization stimulates calcium ion influx through voltage-sensitive calcium channels, raising intracellular concentrations of calcium ions, which induces the secretion, or exocytosis, of insulin. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents
5-(N,N-Hexamethylene)amiloride
D000970 - Antineoplastic Agents
1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one
CFM-2 is a potent and selective non-competitive AMPAR antagonist[1]. CFM-2 possesses anticonvulsant activity in various models of seizures[2].
Actinodaphnine
Actinodaphnine is a member of the class of compounds known as aporphines. Aporphines are quinoline alkaloids containing the dibenzo[de,g]quinoline ring system or a dehydrogenated derivative thereof. Actinodaphnine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Actinodaphnine can be found in sweet bay, which makes actinodaphnine a potential biomarker for the consumption of this food product.
Laetine
Vascular Smooth Muscle Relaxation: The text indicates that sixteen compounds isolated from Hernandia nymphaeifolia, including the three new alkaloids, exhibit effective inhibitory activities on the contraction of vascular smooth muscles. This suggests that these compounds may have potential vasodilatory effects, which could be beneficial in conditions involving vascular constriction, such as hypertension. Antioxidant Properties: Eight of the isolated compounds, which may include (+)-laetine, showed effective antioxidant activities by scavenging the stable free radical DPPH. This implies that these compounds could help protect cells from oxidative stress by neutralizing free radicals, which is important in preventing cellular damage and aging-related diseases. In conclusion, (+)-laetine and the other alkaloids isolated from Hernandia nymphaeifolia possess significant biological activities, particularly in inhibiting vascular smooth muscle contraction and exhibiting antioxidant effects. These findings suggest potential therapeutic applications in cardiovascular health and antioxidant-related therapies. However, further research would be necessary to confirm these activities, understand their mechanisms of action, and assess their potential for clinical use.
Actinodaphnine
An organic heteropentacyclic compound 6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinoline bering additional hydroxy and methoxy substituents at positions 10 and 11 respectively.
Feruloyl dehydrotyramine (isomer of 1654)
Annotation level-3
(7aS)-10-methoxy-(7ar)-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-8t-ol|Michelanugin|Michelanugine
1,3,5-Trihydroxy-4-prenyl-9,10-dihydroacridine-9-one
8,9,10-Trimethoxy-4,5-dihydro-7H-pyrrolo[3,2,1-de]phenanthridine-7-one
1,2-Dihydro-1-(alpha-hydroxy-4-methoxybenzyl)-6,7-methylenedioxyisoquinoline|1,2-Dihydro-1-(hydroxy-p-methoxybenzyl)-6,7-methylenedioxyisoquinoline
5,6-dimethoxy-2-(3-methoxyphenyl)-1H-quinolin-4-one
5,7-Dimethoxy-4-(4-methoxyphenyl)-2(1H)-quinolinone
(Z)-4,6-dimethoxy-7-[(3-methylbuta-1,3-dienyloxy)]furo[2,3-b]quinoline|leptanoine B
5,7,8-trimethoxy-2,3-dihydroindeno[1,2,3-ij]isoquinoline-6-ol|caulophylline E
methyl 1-((2-methyl carbamate)ethyl)-beta-carboline-3-carboxylate
2,9,10-trimethoxy-4H-pyrrolo[3,2,1-de]phenanthridin-7(5H)-one|lycosprenine
(-)-norannuradhapurine|(R)-Norannuradhapurine|Norannuradhapurine
Fissistigine A
Fissistigine A is a natural product found in Xylopia laevigata, Fissistigma oldhamii, and Xylopia parviflora with data available.
Feruloyl dehydrotyramine (isomer of 1655)
Annotation level-3
PC(3:1/0:0)[U]
PC(0:0/3:1)
Norjuzipjine
Nandigerine
(+)-Norushinsunine N-oxide
2-tert-Butoxycarbonylamino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid Methyl ester
3-[3-(4-methylphenoxy)-2-oxopyrrolidin-1-yl]benzoic acid
1-(3,4-Methylenedioxyphenyl)-2-pyrrolidino-1-pentanone hydrochloride
(2R,4R)-3-Benzyloxycarbonyl-4-methyl-2-phenyl-1,3-oxazolidin-5-one
(5s)-3,4,5,6-tetrahydro-5-phenyl-n-(benzyloxycarbonyl)-4(h)-1,4-oxazin-2-one
3-[[2-(2,3-dihydro-1H-inden-5-yloxy)acetyl]amino]benzoic acid
N-(4-METHOXYPHENYL)-2-(3-OXO-1,2,3,4-TETRAHYDROQUINOXALIN-2-YL)ACETAMIDE
Acetic acid, [[(1,1-dimethylethoxy)carbonyl]amino](dimethoxyphosphinyl)-, ethyl ester
tert-butyl 4-fluoro-4-(methylsulfonyloxymethyl)piperidine-1-carboxylate
1-[(4-hydroxy-3-methoxyphenyl)methyl]-7-methoxy-2H-isoquinolin-6-one
3-Piperidinecarboxylicacid, 4-oxo-1-(2-phenylethyl)-, ethyl ester, hydrochloride (1:1)
3-(4-chloro-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester
6-O-tert-butyl 3-O-ethyl 5,7-dihydro-4H-thieno[2,3-c]pyridine-3,6-dicarboxylate
2-benzyl-8-oxa-2-azaspiro[4.5]decane-4-carboxylic acid,hydrochloride
4-(N-[2,4-DIAMINO-6-PTERIDINYLMETHYL]-AMINO)BENZOIC ACID SODIUM SALT
tert-butyl 4-(2-chlorophenoxy)piperidine-1-carboxylate
(R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid
1-ISOPENTYL-7-PHENYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE
2H-1-Benzopyran-2-one,3-[2-(diethylamino)ethyl]-7-hydroxy-4-methyl-, hydrochloride (1:1)
2,3(1H)-Isoquinolinedicarboxylic acid, 3,4-dihydro-, 2-(phenylmethyl) ester
2-((benzyloxy)carbonyl)-1,2,3,4-tetrahydroisoquinoline-7-carboxylic acid
metahexamide
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent
ETHYL 5-BOC-4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDINE-2-CARBOXYLATE
(5r)-3,4,5,6-tetrahydro-5-phenyl-n-(benzyloxycarbonyl)-4(h)-1,4-oxazin-2-one
(2S,4S)-3-Benzyloxycarbonyl-4-methyl-2-phenyl-1,3-oxazolidin
N6-(2-Hydroxyethyl)adenosine
N6-(2-Hydroxyethyl)adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid,styrene
3-[(2,4,6-Trimethoxy-phenyl)-methylene]-indolin-2-one
5-Methoxy-1,2-dimethyl-3-(phenoxymethyl)indole-4,7-dione
4-[5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl]pyridine
(E)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-methoxyphenyl)prop-2-enamide
N-{2-[(4-Cyano-1,1-biphenyl-4-YL)oxy]ethyl}-N-hydroxy-N-methylurea
N2,N2-Dimethylguanosine (incomplete stereochemisrty)
19-Methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.01,16.02,10.04,8]icosa-2,4(8),9,15,17-pentaen-14-one
(3R,4R,5R,6R)-3-amino-6-[2-hydroxy-2-[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]ethyl]oxane-2,4,5-triol
(3Z,5E)-3,5-bis[(2-fluorophenyl)methylidene]piperidin-4-one
(3Z)-3-[(2,4,6-trimethoxyphenyl)methylidene]-1H-indol-2-one
3-(2,3-dihydro-1H-benzo[f]cyclopenta[c]quinolin-4-yl)phenol
N-(2-methoxy-3-dibenzofuranyl)-2-oxolanecarboxamide
5-(2-Ethoxyphenyl)-3-(2-methoxy-6-methyl-3-pyridinyl)-1,2,4-oxadiazole
N-(7-propanoyl-2,3-dihydro-1,4-benzodioxin-6-yl)benzamide
4,5-Dimethylcyclopenta[c]quinolizine-1,2-dicarboxylic acid dimethyl ester
(E)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(2-methoxyphenyl)prop-2-enamide
2-[6-(Carboxymethyl)-9-ethyl-3-carbazolyl]acetic acid
Cyclopropanecarboxylic acid [2-oxo-2-(4-phenoxyanilino)ethyl] ester
2-[[(4-Methyl-2-thiazolyl)amino]-oxomethyl]-1-pyrrolidinecarboxylic acid 2-methylpropyl ester
N-succinimidyl 5-(3-azidopropylamino)-5-oxopentanoate
3-Hydroxy-4-(4-hydroxyphenyl)-1-methyl-5-phenylpiperidine-2,6-dione
CFM 2
CFM-2 is a potent and selective non-competitive AMPAR antagonist[1]. CFM-2 possesses anticonvulsant activity in various models of seizures[2].
N(2),N(2)-Dimethylguanosine
A guanosine where the hydrogens of the amine group at C-2 are substituted by methyl groups.
2′-O-Methyl-8-methyl guanosine
2′-O-Methyl-8-methyl guanosine (m8Gm) is a Z-form RNA stabilizer. 2′-O-Methyl-8-methyl guanosine can markedly stabilize the Z-RNA at low salt conditions[1]. m8Gm-contained oligonucleotides stabilize the Z-DNA under low salt conditions[2].
EF24
EF24 is a curcumin analogue with greater anti-tumor efficacy and oral bioavailability via deactivation of the MAPK/ERK signaling pathway in oral squamous cell carcinoma (OSCC). EF24 treatment increases the levels of activated caspase 3 and 9, and decreases the phosphorylated forms of MEK1 and ERK[1][2].
19-methoxy-4,6-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0³,⁷.0¹⁶,²⁰]icosa-1(20),2(10),3(7),8,16,18-hexaen-18-ol
(1s,19r)-19-methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,15,17-pentaen-12-one
(2z,5s,7z)-15,16-dimethoxy-18-oxa-10-azatetracyclo[7.7.1.1²,⁸.0¹³,¹⁷]octadeca-1(16),2,7,9(17),10,12,14-heptaen-5-ol
(2s)-6-hydroxy-2-(2-hydroxypropan-2-yl)-1h,2h,7h-pyrano[3,4-c]carbazol-4-one
(3s,6s)-6-benzyl-5-hydroxy-3-[(4-hydroxyphenyl)methyl]-3,6-dihydro-1,4-oxazin-2-one
2h,5h,6h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl(4-methoxyphenyl)methanol
4-{[2-(2,4-dimethoxyphenyl)-1,2,4-triazol-3-yl]methyl}phenol
(12r)-19-methoxy-4,6-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0³,⁷.0¹⁶,²⁰]icosa-1(20),2(10),3(7),8,16,18-hexaen-18-ol
(12s,13r)-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol
(12s)-19-methoxy-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(20),2,4(8),9,16,18-hexaen-18-ol
7-methoxyoxoassoanine
{"Ingredient_id": "HBIN013345","Ingredient_name": "7-methoxyoxoassoanine","Alias": "NA","Ingredient_formula": "C18H17NO4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14042","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
Artabonatine B
{"Ingredient_id": "HBIN016912","Ingredient_name": "Artabonatine B","Alias": "NA","Ingredient_formula": "C18H17NO4","Ingredient_Smile": "COC1=C2C(=C3C4=CC=CC=C4C(C5C3=C1CCN5)O)OCO2","Ingredient_weight": "311.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35608","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10614948","DrugBank_id": "NA"}
